Exogenous d-β-hydroxybutyrate lowers blood glucose in part by decreasing the availability of L-alanine for gluconeogenesis.
Adrian Soto-MotaNicholas G NorwitzRhys D EvansKieran ClarkePublished in: Endocrinology, diabetes & metabolism (2021)
The glucose-lowering effect of acutely elevated βHB is partially due to βHB decreasing L-alanine availability as a substrate for gluconeogenesis.